Global
meningococcal vaccines market has the potential of growing at a CAGR
of 14.9% during 2013 and 2019. Growing at this pace, this market that
valued US$1.5 billion in 2012 could achieve a net worth of US$3.7
billion by 2019.
Browse
Meningococcal Vaccines Market Report With Full TOC
http://www.transparencymarketresearch.com/meningococcal-vaccines-market.html
Various
strains of meningococcal bacteria cause serious infection to the thin
lining surrounding the brain and spinal cord. The infection results
in severe brain damage and can be fatal in 50% cases if left
untreated. The high fatality rate of meningococcal disease is
generally considered as a medical emergency. This is why, federal
governments of various countries are actively involved in efforts for
spreading awareness about the severity of the condition. Many
government bodies are also involved in the research, development, and
also the distribution of meningococcal vaccines regionally.
Transparency
Market Research’s report on the global meningococcal vaccines
market presents an all-inclusive overview of the market and its
various segments.
The
report mainly focuses on major market segments based on the types of
vaccines available in the meningococcal vaccine market, such as
Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines,
and the vaccines in pipeline. The product types are further segmented
according to the brands that feature them. An overview of
geographically specific active regional markets is also included in
the report.
Conjugates
are expected to lead the global meningococcal vaccines market in the
future. By observing growth at a CAGR of 12.9%, this product segment
could amass net worth of nearly US$2.5 billion by 2019. Amongst the
various meningococcal vaccines in pipeline currently, Novartis’s
Bexsero is expected to gain market shares at the fastest pace, an
expected 24.7%, during the forecast period.
Request
for customization of this report
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1666
The
Department of Health, UK, states that Baxsero will be the first
vaccine for serogroup B in the meningococcal vaccines market after
its launch in the second quarter of 2014. Pfizer’s MnB rLP2086 is
another potential future vaccine that is currently in its third phase
of trial. The launch of this vaccine, which has received a
Breakthrough Therapy status from the U.S. FDA, is expected to change
the complete outlook of this market by intensifying competition.
Browse
Market Research Articles:
http://www.transparencymarketresearch.com/articles.htm
Geographically,
North America was the leading shareholder of the global meningococcal
vaccines market in 2011 due to government led immunization programs
and favorable research and development initiatives undertaken by
major drug companies in this region. Also, every year nearly 1,000 to
2,600 people in the U.S. contract meningitis from various strains of
the bacteria. However, vaccines for only the serotypes A, C, Y, and
W-135 are available in the U.S. market.
Browse
All Market Research Reports:
http://www.transparencymarketresearch.com/categories.html
Regional
market of Asia Pacific is expected to grow at the fastest pace in the
global meningococcal vaccines market, at an estimated CAGR of 17.1%,
by the end of 2019. Major drivers of growth in these regional markets
are the low manufacturing cost of vaccines, and transfer of novel
manufacturing technologies from developed countries to these
regions.
Browse
Pharmaceutical Market Reports @
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About
Us
Transparency
Market Research is a global market intelligence company, providing
global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. We are
privileged with highly experienced team of Analysts, Researchers, and
Consultants, who use proprietary data sources and various tools and
techniques to gather, and analyze information.
Our
data repository is continuously updated and revised by a team of
research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research
material for business reports.
Contact
Sheela
AK
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Visit:
http://www.europlat.org/
No comments:
Post a Comment